Multiple sclerosis and lung cancer: An unexpected inverse association

QJM: An International Journal of Medicine

Volumn 103, Issue 8, 2010, Pages 625-626

  Handel, A E ^a,b   Joseph, A ^a,b   Ramagopalan, S V ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RISK; CANCER SURVIVAL; CLINICAL TRIAL; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; HUMAN; IMMUNOSURVEILLANCE; LUNG CANCER; META ANALYSIS; MULTIPLE SCLEROSIS; NATURAL KILLER CELL; NOTE; PREVALENCE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SMOKING; SYSTEMATIC REVIEW;

EID: 77955023406     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcq071     Document Type: Note

References (14)

1. Handel AE, Ramagopalan SV. Multiple sclerosis and risk of cancer: a meta-analysis. J Neurol Neurosurg Psychiatry 2010; in press.
2. Handel AE, Giovannoni G, Ebers GC, Ramagopalan SV. Environmental factors and their timing in adult-onset multiple sclerosis. Nat Rev Neurol 2010; 6:156-66.
3. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 2004; 80(Suppl. 6):1678S-88S.
4. Fois AF, Wotton CJ, Yeates D, Turner MR, Goldacre MJ. Cancer in patients with motor neuron disease, multiple sclerosis, and Parkinson's disease: record-linkage studies. J Neurol Neurosurg Psychiatry 2009; 81:215-21.
5. Bahmanyar S, Montgomery SM, Hillert J, Ekbom A, Olsson T. Cancer risk among patients with multiple sclerosis and their parents. Neurology 2009; 72:1170-7.
6. Lebrun C, Debouverie M, Vermersch P, Clavelou P, Rumbach L, de Seze J, et al. Cancer risk and impact of disease-modifying treatments in patients with multiple sclerosis. Mult Scler 2008; 14:399-405.
7. Midgard R, Glattre E, Gronning M, Riise T, Edland A, Nyland H. Multiple sclerosis and cancer in Norway. A retrospective cohort study. Acta Neurol Scand 1996; 93:411-5.
8. Nielsen NM, Rostgaard K, Rasmussen S, Koch-Henriksen N, Storm HH, Melbye M, et al. Cancer risk among patients with multiple sclerosis: a population-based register study. Int J Cancer 2006; 118:979-84.
9. Turner AP, Kivlahan DR, Kazis LE, Haselkorn JK. Smoking among veterans with multiple sclerosis: prevalence correlates, quit attempts, and unmet need for services. Arch Phys Med Rehabil 2007; 88:1394-9.
10. Friend KB, Mernoff ST, Block P, Reeve G. Smoking rates and smoking cessation among individuals with multiple sclerosis. Disabil Rehabil 2006; 28:1135-41.
11. Driver JA, Logroscino G, Buring JE, Gaziano JM, Kurth T. A prospective cohort study of cancer incidence following the diagnosis of Parkinson's disease. Cancer Epidemiol Biomarkers Prev 2007; 16:1260-5.
12. Brouchet L, Valmary S, Dahan M, Didier A, Galateau-Salle F, Brousset P, et al. Detection of oncogenic virus genomes and gene products in lung carcinoma. Br J Cancer 2005; 92:743-6.
13. Morandi B, Bramanti P, Bonaccorsi I, Montalto E, Oliveri D, Pezzino G, et al. Role of natural killer cells in the pathogenesis and progression of multiple sclerosis. Pharmacol Res 2008; 57:1-5.
14. Komaru A, Ueda Y, Furuya A, Tanaka S, Yoshida K, Kato T, et al. Sustained and NK/CD4+ T cell-dependent efficient prevention of lung metastasis induced by dendritic cells harboring recombinant Sendai virus. J Immunol 2009; 183:4211-9.